期刊文献+

变链素的纯化

Purification of mutacin
下载PDF
导出
摘要 目的从变异链球菌临床株中分离纯化变链素,为进一步从分子水平研究变链素奠定基础。方法通过抑菌活性检测,从变异链球菌临床株中选择出抑菌活性较强的菌株。用氯仿抽提法从该菌株培养液中粗提变链素,经固相萃取和反相高效液相色谱(RP-HPLC)对粗提物进行纯化。结果获得变链素活性较强的菌株1G。从其200 mL液体培养基中粗提出变链素约15μg,经固相萃取柱洗脱,再经过RP-HPLC的2次纯化,得到有抑菌活性的成分,此为纯化的变链素。结论变链素相对分子质量小,分离提纯步骤复杂,本实验得到纯化的变链素,为下一步研究变链素的氨基酸序列和基因序列奠定了基础。 Objective To purify mutacin produced from isolated Streptococcus mutans(S.mutans) strains in order to,contribute to molecular biological research of mutacin.Methods The antibacterial activity of 80 isolated strains was tested by the stab culture technique against Streptococcus oralis ATCC 10557.The mutacin produced by strain 1G,was initially purified by solid-phase extraction(SPE) after crude extraction by chloroform.And then the active substances were purified by twice reversed-phase high performance liquid chromatography(RP-HPLC).The purified target peptide(mutacin) was collected and freeze-dried for further study.Results The greatest active strain of these S.mutans isolates,the strain 1G was obtained.Roughly 15 μg crude mutacin was extracted from 200 mL liquid medium of this strain 1G.The purified mutacin through SPE and twice RP-HPLC was obtained.Conclusion It was much complex to separate and purify mutacin due to its small molecular mass,and extracting and purifying of mutacin may make an important contribution to the further research of mutacin.
出处 《华西口腔医学杂志》 CAS CSCD 北大核心 2010年第5期565-569,共5页 West China Journal of Stomatology
基金 国家自然科学基金资助项目(30640074) 安徽省教育厅重点基金资助项目(KJ2007A027) 安徽医科大学博士基金资助项目(2004)
关键词 变异链球菌 变链素 反相高效液相色谱 Streptococcus mutans mutacin reversed-phase high performance liquid chromatography
  • 相关文献

参考文献19

  • 1樊明文.牙体牙髓病学[M].2版.北京:人民卫生出版社,2004.214,250-252.
  • 2Hamada S,Onshima T.Inhibitory spectrum of a bacteriocinlike substance (mutacin) produced by some strains of Streptococcus mutans[J].J Dent Res,1975,54(1):140-145.
  • 3Mota-Meira M,LaPointe G,Lacroix C,et al.MICs of mutacin B-Ny266,nisin A,vancomycin,and oxacillin against bacterial pathogens[J].Antimicrob Agents Chemother,2000,44(1):24-29.
  • 4Chen P,Qi FX,Novak J,et al.Effect of amino acid substitutions in conserved residues in the leader pepfide on biosynthesis of the lantibiotic mutacin Ⅱ[J].FEMS Microbinl Lett,2001,195 (2):139-144.
  • 5Qi F,Chen P,Canfield PW.Purification of mutacin Ⅲ from group Ⅲ Streptococcus mutans UA787 and genetic analyses of mutacin Ⅲ biosynthesis genes[J].Appl Environ Microbiol,1999,65 (9):3880-3887.
  • 6Qi F,Chen P,Caufield PW.The group Ⅰ strain of Streptococcus mutans,UA140,produces both the lantibiotic mutacin Ⅰ and a nonlantibiotic bacteriocin,mutacin Ⅳ[J].Appl Environ Microbiol,2001,67(1):15-21.
  • 7Novak J,Caufield PW,Miller EJ.Isolation and biochemical characterization of a novel lantibiotic mutacin from Streptococcus mutans[J].J Bacteriol,1994,176(14):4316-4320.
  • 8Balakrishnan M,Simmonds RS,Carne A,et al.Streptococcus mutans strain N produces a novel low molecular mass non-Lantihiotic bacteriocin[J].FEMS Microbiol Lett,2000,183(1):165-169.
  • 9Balakrishnan M,Simmonds RS,Kilian M,et al.Different bacteriocin activities of Streptococcus mutans reflect distinct phylogenetic lineages[J].J Med Microbiol,2002,51(11):941-948.
  • 10Hillman JD,Novak J,Sagura E,et al.Genetic and biochemical analysis of mutacin 1140,a lantibiotic from Streptococcus mutans[J].Infect Immun,1998,66(6):2743-2749.

二级参考文献46

  • 1李领,刘天佳,胡晓燕,杨柳,柳雯.变链素活性与变形链球菌基因多态性的关系研究[J].中国微生态学杂志,2007,19(3):253-255. 被引量:4
  • 2Monchois V, Vignon M, Russel RRB. Mutagenesis of asp-569 of glucosyltransferase I glucansucrase modulates glucan and oligosaccharide synthesis. Appl Enivron Microbiol,2000,66(5) : 1923.
  • 3MacGregor EA, Jespersen HM, Svensson B. A circularly permuted α-amylase-type alpha/beta- barrel structure in glucan-synthesizing glucosyltranferase. FEBS lett, 1996, 378(3): 263.
  • 4Tsumori H, Minai T, Kuramitsu HK. Identification of essential amnio acids in the Streptococcus mutans glucosyltransferases. J Bactoeriol, 1997,179(11): 3391.
  • 5Shimamura A, Nakano YJ, Mukasa H, et al. Identification of amino acid residues in Streptococcus mutans glucosyltransferases influencing the structure of the glucan product.J Bacteriol, 1994,176(16) : 4845.
  • 6Smith DJ, Shousthtari B, Heachel RL, et al. Immunogenicity and proctective immunity induced by synthetic peptides associated with a catalytic suhdomain of mutans group streptococcal glucosyltransferase. Infect Immun, 1997,65 (11) :4424.
  • 7McGhee JR, Michalek SM, Webb J, et al. Effective immunity to dental caries: Protection of gnotobiotic rats by local immunization with Streptococcus rnutans. J Immunol, 1975,114(1) : 300.
  • 8Van de Rijn I, Bleiweis AS, Zabriskie JB. Antigens in Streptococcus mutans cross reactive with human heart muscle. J Dent Res, 1976,55( Sepc issue) : C59.
  • 9Davies DG, Parsek MR, Pearson JP, et al.The involvement of cell-to-cell signals in the development of a bacterial biofilm. Science,1998,280(5361):295
  • 10Hillman JD, Brooks TA, Michalek SM, et al.Construction and characterization of an effector strain of streptococcus mutans for replacement therapy of dental caries.Infect Imun, 2000,68(2):543.

共引文献54

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部